Kymera Therapeutics Inc. (KYMR): Price and Financial Metrics

Kymera Therapeutics Inc. (KYMR): $50.10

1.47 (+3.02%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add KYMR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#318 of 332

in industry

KYMR Price/Volume Stats

Current price $50.10 52-week high $53.27
Prev. close $48.63 52-week low $16.94
Day low $50.10 Volume 204
Day high $50.10 Avg. volume 586,887
50-day MA $47.33 Dividend yield N/A
200-day MA $40.68 Market Cap 3.24B

KYMR Stock Price Chart Interactive Chart >


Kymera Therapeutics Inc. (KYMR) Company Bio


Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.


KYMR Latest News Stream


Event/Time News Detail
Loading, please wait...

KYMR Latest Social Stream


Loading social stream, please wait...

View Full KYMR Social Stream

KYMR Price Returns

1-mo 11.83%
3-mo 14.38%
6-mo 43.35%
1-year 176.95%
3-year -18.27%
5-year N/A
YTD 96.78%
2023 2.00%
2022 -60.69%
2021 2.40%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!